Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Lycia Therapeutics, Inc. LYCA

Full chart Compare
Set alert

Price alert · LYCA

All alert types
28.67 USD -0.25 (-0.86%)

Nov 5, 2026, 3:50 PM EST

27.94 Day range 29.34
22.19 52-week range 36.49
YTD
-4.43%
1 year
-4.43%

Revenue & Expenses

Other Income → Expenses: $4.73MExpenses → Selling, General & Admin: $6.11MExpenses → Research & Development: $40.51MExpenses → Other Operating Expenses: $1.53MExpenses → Interest Expense: $31.00KIncome Tax Benefit → Expenses: $249.00KGross Profit → Expenses: $6.74MRevenue → Gross Profit: $6.74MNet Loss → Expenses: $36.46MOther Income$4.73MIncome Tax Benefit$249.00KGross Profit$6.74MNet Loss$36.46MExpenses$48.18MSelling, General & Admin$6.11MResearch & Development$40.51MOther Operating Expenses$1.53MInterest Expense$31.00KRevenue$6.74M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Income statement

Full income statement How to read it
LYCA annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
6.74M14.94M
6.74M14.94M
-41.41M-32.53M
-36.46M-26.50M
-2.59-1.98

Balance sheet

Full balance sheet How to read it
LYCA annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
19.42M30.74M
97.22M150.91M
8.21M26.50M
2.75M4.77M
-113.34M-77.93M

Cash flow

Full cash flow How to read it
LYCA annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
-51.36M-29.50M
39.96M-59.71M
77.00K106.42M
-159.00K-1.27M
-11.32M17.21M